US Patent Issued to Gnubiotics Sciences on Feb. 17 for "Compositions derived from gastrointestinal tract mucins" (Swiss Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,550,924, issued on Feb. 17, was assigned to Gnubiotics Sciences SA (Epalings, Switzerland).

"Compositions derived from gastrointestinal tract mucins" was invented by Adeyemi Adesokan (Lausanne, Switzerland), Sara Vidal Lopez (Spiez, Switzerland) and Yong Miao (Lausanne, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods and compositions comprising glycopeptides obtained from gastrointestinal sources that have superior microbiota effects. Such compositions are advantageous for food stuff, including infant formulations."

The patent was filed on Jan. 31, 2020, under Application No. 17/427,911.

*For further information, inclu...